KR20060111422A - Drink contain ingrediet of sea weed fusiforme - Google Patents
Drink contain ingrediet of sea weed fusiforme Download PDFInfo
- Publication number
- KR20060111422A KR20060111422A KR1020060088836A KR20060088836A KR20060111422A KR 20060111422 A KR20060111422 A KR 20060111422A KR 1020060088836 A KR1020060088836 A KR 1020060088836A KR 20060088836 A KR20060088836 A KR 20060088836A KR 20060111422 A KR20060111422 A KR 20060111422A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- sea weed
- onion
- fusiforme
- Prior art date
Links
- 241001474374 Blennius Species 0.000 title abstract 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 17
- 235000013361 beverage Nutrition 0.000 claims abstract description 11
- 244000269722 Thea sinensis Species 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 5
- 235000021419 vinegar Nutrition 0.000 claims abstract description 5
- 239000000052 vinegar Substances 0.000 claims abstract description 5
- 244000291564 Allium cepa Species 0.000 claims abstract description 3
- 244000241838 Lycium barbarum Species 0.000 claims description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 10
- 230000036772 blood pressure Effects 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 2
- 244000201986 Cassia tora Species 0.000 abstract 1
- 235000014552 Cassia tora Nutrition 0.000 abstract 1
- 241001632410 Eleutherococcus senticosus Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 230000001631 hypertensive effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 24
- 241000234282 Allium Species 0.000 description 15
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 206010003210 Arteriosclerosis Diseases 0.000 description 7
- 208000011775 arteriosclerosis disease Diseases 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009207 exercise therapy Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- VNFYMAPAENTMMO-UHFFFAOYSA-N 5-chloro-2-methylquinoline Chemical compound ClC1=CC=CC2=NC(C)=CC=C21 VNFYMAPAENTMMO-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000005255 Allium cepa Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 description 1
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241001559542 Hippocampus hippocampus Species 0.000 description 1
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000264279 Sargassum fusiforme Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940008075 allyl sulfide Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229920000080 bile acid sequestrant Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- ALVPFGSHPUPROW-UHFFFAOYSA-N dipropyl disulfide Chemical compound CCCSSCCC ALVPFGSHPUPROW-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- -1 lignan glycoside Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 톳 성분을 함유하는 음료 조성물에 관한 것으로, 더욱 상세하게는 톳, 양파, 오가피, 구기자, 결명자차, 식초를 포함하여 구성됨으로써 고혈압 증상이 있는 환자가 음용하는 경우 혈압강하 효능이 있을 뿐만 아니라, 일반인이 일상생활에서 상시 음용하는 경우 체내 각 기관을 건강하게 유지하며 성인질환 원인을 예방할 수 있는 음료 조성물을 제공하는 것이다.The present invention relates to a beverage composition containing 톳 component, more specifically, 톳, onion, cucumber, gojija, gyeongjaja tea, vinegar is composed by the high blood pressure symptom when drinkable by the patient as well as having a hypotensive effect Rather, when the general public to drink at all times in everyday life to maintain the health of each organ in the body and to provide a beverage composition that can prevent the cause of adult diseases.
지방성분의 일종일 콜레스테롤은 성인병의 주범인 동맥경화를 일으키는 물질로 널리 알려져 있다.Cholesterol, which is a type of fat, is widely known as a substance that causes arteriosclerosis, which is the main cause of adult disease.
현대화가 진행되고 생활이 윤택해지면서 현대인들의 식습관은 종래에 비하여 야채의 섭취량보다 육류를 포함하는 동물성 지방의 섭취가 많아지고, 운동부족 등으로 인하여 비만은 물론 혈관내 콜레스테롤의 증가로 고혈압, 동맥경화증과 같은 성인병이 큰 문제로 대두 되고 있다.As modernization progresses and life improves, modern people's eating habits are more intake of animal fats, including meat, than vegetables, and hypertension and arteriosclerosis due to obesity and increased vascular cholesterol due to lack of exercise. Adult diseases such as these are a big problem.
종래 고혈압의 원인인 콜레스테롤 수치를 낮추기 위해서 약물요법, 식이요법, 운동요법 등이 일반적으로 이루어져 왔다. 예를 들면, 약물 요법의 경우에는 스타틴(statin)계열, 담즙산 결합레진(bile-acid-binding resin), 니코틴산(nicotinic acid)계열, 피브린스타틴(statin) 계열의 약물을 주제로 또는 보조제와 함께 처방하고 있으나, 각 약물별로 복통, 근육통, 불면증, 피부작열감, 변비와 같은 부작용과 일정 기간 마다 간기능 검사 등이 필요 하는 등의 불편함이 있다.In order to lower the cholesterol level, which is a cause of conventional hypertension, drug therapy, diet, exercise therapy, etc. have been generally made. For example, in the case of drug therapy, drugs such as statins, bile-acid-binding resins, nicotinic acid, and fibrinstatin drugs may be used as themes or with supplements. However, there are inconveniences such as side effects such as abdominal pain, muscle pain, insomnia, skin burning, constipation, and liver function tests for a certain period for each drug.
또한, 식이요법의 경우 주로 행하는 것은 저지방식(low lipid diet)을 섭취함으로써 콜레스테롤 수치를 낮추는 것인데, 식이요법으로 낮아질 수 있는 콜레스테롤의 수치는 약 5～10％가량으로 콜레스테롤은 대부분 체내에서 합성되고 외부에서 섭취하는 양은 많지 않으므로 식이요법으로 혈중 콜레스테롤의 수치를 크게 낮추지는 못하는 단점이 있다.In addition, the diet is mainly to lower the cholesterol level by eating a low lipid diet (low lipid diet), the cholesterol level that can be lowered by the diet is about 5-10%, cholesterol is mostly synthesized in the body Ingestion is not much, so the diet does not significantly lower blood cholesterol levels.
마지막으로 병행되는 것이 운동요법이나 운동요법이 콜레스테롤 수치를 낮추는데 크게 도움이 되지 않는다는 것은 널리 알려진 사실이다.Finally, it is well known that exercise therapy or exercise therapy does not help significantly lower cholesterol levels.
본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로, 인체에 무해하여 부작용의 우려가 없으면서 혈액내 콜레스테롤을 저하시켜 혈압을 정상으로 유지시킬 수 있는 자연 친화적 성분인 톳, 양파를 주성분으로 포함하여 구성되는 음료 조성물에 관한 것이다.The present invention has been made in order to solve the above problems, harmless to the human body, without the risk of side effects, including the 친화적, onion, which is a natural friendly ingredient that can maintain the normal blood pressure by lowering cholesterol in the blood It relates to a beverage composition constituted.
본 발명의 목적은The object of the present invention is
톳 100중량부에 대하여 양파 50 내지 80중량부, 가시오가피 1 내지 5중량부, 구기자 1 내지 5중량부, 결명자차 1 내지 5중량부, 식초 1 내지 5중량부를 포함하 여 구성되는 것을 특징으로 하는 톳 성분을 함유한 음료 조성물을 제공하는 것이다.양파 50 to 80 parts by weight of onion, 1 to 5 parts by weight of gojipi, 1 to 5 parts by weight of goji berry, 1 to 5 parts by weight of tea seedlings, 1 to 5 parts by weight of vinegar It is to provide a beverage composition containing a component.
본 발명에서 사용된 톳은 갈조식물 모자반과 바닷말(Hizikia fusiforme)로 한국 주문진 이남에서 주로 나고 크기는 10～60cm, 제주에서 나는 것은 1m 이상이다. 톳은 칼슘, 요오드, 철 등의 무기염류가 많이 포함되어 있어 혈관경화를 막아주고 상용으로 먹으면 치아가 건강해지며 머리털이 윤택해지고, 임산부인 경우에는 태아의 뼈를 튼튼하게 해주는 등 예로부터 기호식품의 하나로서 일본사람들의 섭취가 많아 일본 후생성에서는 9월15일을 톳의 날로 정해 톳의 복용을 적극 권장하고 있으며 그로 인해 한국에서 생산되는 톳의 90％ 이상이 일본으로 수출되고 있는 실정이다.As used in the present invention, 갈 is a brown algae plant and a sea horse (Hizikia fusiforme), mainly in south Korea Jumunjin, the size is 10 ~ 60cm, flying in Jeju is more than 1m. Contains a lot of inorganic salts such as calcium, iodine, iron, etc. It prevents vascular hardening, and when eaten commercially, teeth are healthy, hair is hydrated, and in the case of pregnant women, fetal bones are strengthened. As a result, Japanese intake is so high that Japan's Ministry of Health, Labor and Welfare has decided to take September 15 as the day of 톳, so that more than 90% of the 있으며 produced in Korea is exported to Japan.
한 예로 고지혈증을 유발한 흰쥐에게 톳을 투여한 결과 고지혈증과 고콜레스테롤을 억제하는 결과를 얻을 수 있음이 밝혀졌다. 또한 톳은 심혈관계 질환의 대표질환인 바로 동맥경화를 낮추는 역할을 한다. 이 동맥경화의 발생 지표인 동맥경화지수를 측정한 결과 톳을 섭취하면 동맥경화지수가 저하되는 것으로 나타났다고 한다.As an example, it was found that the administration of 톳 to rats that induced hyperlipidemia can suppress hyperlipidemia and high cholesterol. 톳 also serves to lower arteriosclerosis, a representative disease of cardiovascular disease. As a result of measuring the arteriosclerosis index, which is an index of atherosclerosis, the arteriosclerosis index was found to be lowered when ingested.
아울러, 톳은 식이섬유가 풍부한 것으로 알려져 있는데, 오이에 비해 2.5배나 많고 식이섬유가 많은 것으로 알려진 사과나 배보다도 풍부하다.In addition, 톳 is known to be rich in dietary fiber, 2.5 times more than cucumber and rich in fiber than apples and pears are known to have a lot of fiber.
본 발명에서 사용된 톳은 친환경지대에서 채취한 것으로 톳에 잔존하는 염분이 없어질 때까지 식수로 8 내지 10회에 걸쳐 세척을 하고 약 24시간～72시간 동안 물에 담궈 두어 염분이 제거된 것을 사용하도록 하며 본 발명의 주성분이 된다.톳 used in the present invention is taken from the eco-friendly zone and washed 8 to 10 times with drinking water until there is no salt remaining in the 톳 and soaked in water for about 24 to 72 hours to remove the salt It is used and becomes the main component of the present invention.
본 발명에서 사용된 양파는 외떡잎식물 백합목 백합과의 두해살이풀(Allium cepa)로서 꽃은 9월에 흰색으로 피고 잎 사이에서 나온 꽃줄기 끝에 산형꽃 차례를 이루며 많은 수가 달려 공처럼 둥근 모양이다. 양파는 주로 비늘 줄기를 식용으로 하는데, 비늘 줄기에서 나는 독특한 냄새는 이황화프로필, 황화알릴 등의 화합물 때 문이다. 또한 비늘 줄기는 각종 비타민과 함께 칼슘, 인산 등의 무기질이 들어 있어 혈액 중의 유해 물질을 제거하는 작용이 있다. 비늘줄기는 샐러드나 수프, 그리고 고기 요리에 많이 사용되며 각종 요리에 향신료 등으로 이용된다.Onion used in the present invention is a monocotyledonous genus Liliumaceae liliaceae perennial (Allium cepa), the flowers bloom in September in white, forming a turn of flowers in the end of the stem stems between the leaves and rounded like a ball. Onions are mainly used for stalks of scales, and the peculiar smell of scales is due to compounds such as propyl disulfide and allyl sulfide. In addition, the scale stem contains minerals such as calcium and phosphoric acid along with various vitamins to remove harmful substances in the blood. Scales are often used in salads, soups, and meat dishes, and are used as spices in various dishes.
또한, 양파는 혈액 속의 불필요한 지방과 콜레스테롤을 녹여 없애는 것으로 알려져 있고, 그 결과 동맥경화와 고지혈증을 예방하고 치료하는데 이용되고 있고 혈관을 막는 혈전 형성을 방지함과 동시에 혈전을 분해해서 없애버리는 작용을 함으로써 협심증, 심근경색, 뇌연화증, 뇌졸증 등의 질병을 예방, 치료할 수 있다.In addition, onions are known to dissolve and eliminate unnecessary fat and cholesterol in the blood. As a result, onions are used to prevent and treat arteriosclerosis and hyperlipidemia, and prevent the formation of blood clots that block blood vessels. It can prevent and treat diseases such as angina pectoris, myocardial infarction, stroke and stroke.
아울러, 양파는 혈액을 묽게 하는 작용으로 혈액의 점도(粘度)를 낮춰 끈적거리지 않고 흐르기 쉬우며 맑고 깨끗한 혈액으로 만들고, 혈압을 내리는 작용도 현저하여 고혈압의 예방과 치료에 탁월하다.In addition, onion is a blood thinning action to lower the viscosity of the blood (粘度) is not sticky and easy to flow to make clean and clear blood, the action of lowering blood pressure is outstanding for the prevention and treatment of high blood pressure.
본 발명에서 사용된 양파는 톳 100중량부에 대하여 10 내지 80중량부로 사용하는 것이 고혈압 예방 및 치료를 위하여 바람직하고, 가장 바람직하게는 75중량부이다.Onion used in the present invention is preferably used for 10 to 80 parts by weight based on 100 parts by weight of 고 for the prevention and treatment of hypertension, most preferably 75 parts by weight.
본 발명에서 사용되는 양파는 특별히 가공이 필요한 것은 아니고, 일반적으로 구입할 수 있는 양파의 껍질을 제거하고 물에 수차례 세척하여 사용할 수 있다.The onion used in the present invention does not need to be processed in particular, and can be used by removing the skin of a commercially available onion and washing it with water several times.
본 발명의 목적을 달성하기 위하여 가시오가피가 사용되는데, 가시오가피의 정식학명은 아칸토파낙스(ACANTHOPANAX) 이며, 이는 'ACANTHO'라는 가시가 있는 나무이고, 'PANAX'는 만병을 치료한다는 뜻으로 "만병을 치료하는 가시가 있는 나무이다"라는 의미를 담고 있다.In order to achieve the object of the present invention, prickly gingiva is used, the official scientific name of prickly pear is ACANTHOPANAX, which is a thorny tree called 'ACANTHO', and 'PANAX' means to cure all diseases. It is a tree with a thorn to heal. "
약리실험에서 가시오가피는 강심, 강장작용, 중추신경계통흥분작용, 방사선피해, 유기체의 특이적 저항성을 높이는 작용 등이 있다고 한다. 가시오가피의 맛은 맵고 쓰며 성질은 따뜻하며 간경과 신경에 작용하여 풍습을 없애고 기를 돋우고 정수를 불러일으키며 이외에 뼈와 힘줄을 튼튼하게 하는 작용을 한다.In pharmacological experiments, thorny ginseng has a strong effect on the core, tonic, central nervous system excitement, radiation damage, and the specific resistance of the organism. The taste of splinters is spicy and bitter, and its properties are warm. It acts on the liver and nerves, eliminating customs, invigorating and purifying essence, and strengthening bones and tendons.
구체적 용도로는 간과 신장의 허약으로 힘줄과 뼈가 연약하여 다리를 잘 쓰지 못하는 증세, 소아의 걸음이 늦어지는데 쓰이고, 풍습으로 인한 허리와 무릎통증, 팔다리가 오그라드는 증세와 각기병 등에 사용된다.Specific uses include weakness in the tendons and bones as a weakness in the liver and kidneys, which makes it difficult to use the legs, slows the pace of children, and causes waist and knee pains due to the customs, and symptoms such as gradation of limbs.
오가피의 주성분은 리그난 배당체인 오가피배당체(anthoside B.D)가 있고, 면역성을 높여주는 수용성 다당체가 분리되어 있고, 다양한 배당체 외에 비타민 B,C, 코발트, 망간 등 비타민과 미네랄이 풍부하여 광범위하게 이용될 수 있는 약초이다.Ogapi's main component is lignan glycoside, anghoside glycoside (anthoside BD), water-soluble polysaccharides that enhance immunity are separated, and in addition to various glycosides, vitamin B, C, cobalt, manganese and other vitamins and minerals can be widely used. It is an herbal medicine.
본 발명에서 사용된 가시오가피는 톳 100중량부에 대하여 1 내지 5중량부가 사용되는 것이 바람직하며, 가장 바람직하게는 1.5중량부이다.It is preferable that 1 to 5 parts by weight is used with respect to 100 parts by weight, and most preferably 1.5 parts by weight for use in the present invention.
본 발명에서 사용된 구기자는 구기자 나무의 열매로 달걀모양 또는 긴 타원형이고 길이 1.5～2.5cm로 7월부터 붉게 익어 7～11월 하순에 수확한다.The wolfberry used in the present invention is an egg-shaped or long oval with the fruit of the wolfberry tree and ripens red from July with a length of 1.5-2.5 cm and is harvested in late July-November.
단백질, 지방, 당질, 칼슘, 인, 철분, 베타인, 루틴, 비타민(A,B1,B2,C) 등이 들어 있어 흡수가 빠르다. 한방에서는 강장제, 해열제로 쓰고 간기능 보호작용 이 뛰어나 부작용이 별로 없다. 시력을 좋게 하고 당뇨병 등의 성인병을 예방하며 폐와 신장의 기능을 좋게 한다.Proteins, fats, sugars, calcium, phosphorus, iron, betaine, rutin, vitamins (A, B1, B2, C), etc. are contained, so absorption is quick. In oriental medicine, it is used as a tonic and antipyretic. Improves vision, prevents adult diseases such as diabetes, and improves lung and kidney function.
또한, 약리실험 결과에 따르면 체중증가작용, 간보호작용, 콜레스테롤 강하작용, 혈압 및 혈당량 강하작용 등을 하는 것으로 밝혀져 있다. 민간에서는 중년기와 노년기에 올 수 있는 고혈압, 신경통, 동맥경화증 빈혈과 암 예방에 노인성 갈증에는 구기자잎 10～20g을 달여 하루에 3번 마시는 사례가 있다.In addition, the results of pharmacological experiments are found to increase weight, hepatoprotective action, cholesterol lowering action, blood pressure and blood sugar lowering action. In the private sector, 10 ~ 20g of goji berry leaves are consumed three times a day for the prevention of hypertension, neuralgia, arteriosclerosis anemia and cancer, which can come in middle and old age.
본 발명에서 사용된 구기자는 1 내지 5중량부가 혈압을 낮추고, 당뇨병을 예방할 수 있는 효과를 발휘하는데 적합하고, 가장 바람직하게는 1중량부이다.The wolfberry used in the present invention is 1 to 5 parts by weight is suitable for exerting the effect of lowering blood pressure and preventing diabetes, most preferably 1 part by weight.
본 발명에서 사용된 결명자차는 추출물을 사용하는 것이 바람직하다. 본 발명에서 사용된 결명자차 추출물은 물, 바람직하게는 지장수를 가열하여 방냉한 후 온도가 70～80℃가 되면 결명자열매을 넣고 10 내지 30분 후 결명자차물만 걸러낸 후 다른 성분들과 혼합하여 사용할 수 있다. 안즈라퀴논 유도체라는 성분이 있어 강장, 이뇨, 고혈압, 위가 약한데 좋으며 간장과 신장의 기운을 돕고 혈색을 좋게하는 데 도움을 준다고 기록되어 있다.It is preferable to use the extract as a deficiency tea used in the present invention. In the present invention, the Cassia japcha tea extract is heated to cool the water, preferably Jijangsu, the temperature is 70 ~ 80 ℃ and then put the Cassia berry fruit after 10 to 30 minutes to filter only the Jajaja tea after mixing with other components Can be. Anzraquinone derivatives have a component called tonic, diuretic, high blood pressure, and weak stomach, and it is said to help the liver and kidneys, and to help improve color.
이하, 본 발명을 실시예를 들어 더욱 상세히 설명하고자 하나 본 발명이 하기 실시예에 의하여 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited by the following Examples.
실시예Example
1) 제주에서 채취한 톳 2kg을 염분이 없어질 때까지 식수로 8회 정도 갈아주며 약 72시간 동안 물에 담가두어 염분을 제거한다.1) 2kg of 채취 collected from Jeju is changed into drinking water about 8 times until salt disappears and soaked in water for 72 hours to remove salt.
2) 양파 1.5kg을 준비하여 껍질을 제거하고 세척한 후 물기를 제거하여 둔 다.2) Prepare 1.5kg of onion, remove the skin, wash and remove the water.
3) 톳과 양파에 가시오가피 30g, 구기자 20g, 지장수 12ℓ를 넣은 후 100℃에 도달하였을 때부터 추가로 1시간 30분에서 2시간 안 추가로 가열한 후 고운 체를 이용하여 액상만 추출한 후 방냉한다.3) After adding 30 g of thorny stalks, 20 g of goji berry, 12 liters of jijangsu into the 톳 and onion, after heating to 100 ° C for an additional 1 hour 30 minutes, it is heated for an additional 2 hours. .
4) 별도로 결명자차추출물을 준비하는데, 결명자차 추출물은 지장수 4ℓ를 넣은 후 가열하여 100℃에 도달하면 방냉하고, 70～80℃ 정도가 되면 결명자 20g을 넣고 10～20분 후 결명자차물을 추출한다.4) Separately prepare the Cassia japcha tea extract, add 4 liters of Jijasoo water and heat it to reach 100 ℃ by cooling it, and when it reaches about 70 ~ 80 ℃, add 20 g of Cassia japonicum and extract it after 10-20 minutes. .
5) 톳, 양파, 가시오가피, 구기자 추출액에 결명자차 추출물을 혼합하는데, 이 때 현미 식초를 6g 가하여 음료 조성물을 수득한다.5) Tofu, onion, thorn stem, gojija extract is mixed with Culja Jaja tea extract, at which time 6g of brown rice vinegar is added to obtain a beverage composition.
상기와 같이 수득한 음료를 상시 혈압 150 이상의 고혈압 증상이 있는 환자들에게 1일 3회 200㎖씩 3개월 동안 꾸준히 음용하도록 한 후 혈압을 측정한 바에 따르면 혈압이 정상수치로 떨어짐을 확인할 수 있었다.The beverage obtained as described above was steadily drinking 200 ml of three times a day for patients with symptoms of hypertension over 150 at regular blood pressure, and then the blood pressure was found to drop to the normal value.
이상에서 살펴본 바와 같이, 본 발명에 따른 톳과 양파를 주성분으로 함유하는 음료를 상시 복용하는 경우 고혈압이 있는 환자의 혈압이 정상으로 유치될 뿐만 아니라, 혈압계에 문제가 없는 경우에는 성인병을 사전에 예방할 수 있는 효과가 있다.As discussed above, when the beverage containing 톳 and onion as a main ingredient according to the present invention is always taken, the blood pressure of the patient with hypertension is not only attracted to normal, but when there is no problem in the blood pressure monitor, the adult disease is prevented in advance. It can be effective.
Claims (1)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060088836A KR100758930B1 (en) | 2006-09-11 | 2006-09-11 | drink contain ingrediet of sea weed fusiforme |
| PCT/KR2007/004357 WO2008032958A1 (en) | 2006-09-11 | 2007-09-10 | Beverage composition using sea weed fusiforme and onion for the prevention of hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060088836A KR100758930B1 (en) | 2006-09-11 | 2006-09-11 | drink contain ingrediet of sea weed fusiforme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20060111422A true KR20060111422A (en) | 2006-10-27 |
| KR100758930B1 KR100758930B1 (en) | 2007-09-17 |
Family
ID=37620173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020060088836A KR100758930B1 (en) | 2006-09-11 | 2006-09-11 | drink contain ingrediet of sea weed fusiforme |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR100758930B1 (en) |
| WO (1) | WO2008032958A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100986974B1 (en) * | 2008-01-21 | 2010-10-11 | 김종웅 | Method of manufacturing a lotus tea drink using loess water |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2764017B1 (en) * | 1997-05-30 | 1999-08-13 | Valeo | TORSION DAMPING DEVICE, PARTICULARLY FOR A CLUTCH FRICTION OF A MOTOR VEHICLE |
| JP2000004847A (en) * | 1998-06-17 | 2000-01-11 | Sakae Watanabe | Health food prepared by formulating shiitake mushroom, sesame, soybean nd the like to see weeds and its production |
| KR100411508B1 (en) * | 2001-02-23 | 2003-12-18 | 대한민국 | Seaweed beverage mixed brown algae mold of green color and its processing knowhow |
| JP3721432B2 (en) * | 2002-03-12 | 2005-11-30 | 株式会社コムス | Process for producing food for beverages made from seaweed |
| KR100463266B1 (en) * | 2002-09-24 | 2004-12-23 | 정봉우 | Beverage Composition of Onion Comprising Gluconic Acid and Their Manufacturing Method |
| JP2006089384A (en) * | 2004-09-21 | 2006-04-06 | Taiyo Kagaku Co Ltd | Thrombus preventing composition |
-
2006
- 2006-09-11 KR KR1020060088836A patent/KR100758930B1/en not_active IP Right Cessation
-
2007
- 2007-09-10 WO PCT/KR2007/004357 patent/WO2008032958A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008032958A1 (en) | 2008-03-20 |
| KR100758930B1 (en) | 2007-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101090284B1 (en) | Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof | |
| CN101816440B (en) | Stewed shrimps for health care and nourishment having effects of nourishing yin, strengthening yang and supplementing calcium | |
| KR20160087114A (en) | Food additive containing flowers | |
| KR100663081B1 (en) | Additive consisting mainly of the method hereof | |
| CN104026455A (en) | Health care dumplings and preparation method thereof | |
| KR20130133946A (en) | Soybean paste comprising herbal medicine and manufacturing method thereof | |
| KR100815375B1 (en) | Chickens-daebojungtang using the chickens and medicinal herbs and method preparing thereof | |
| KR101148006B1 (en) | Manufacturing Process of Ginseng Chicken Broth Including Trepang and Ginseng Chicken Broth Manufactured thereby | |
| KR20170062755A (en) | Method of using the medicinal plants Eel Soup | |
| KR100891689B1 (en) | Chinese Herb Duck Tea and Manufacturing Method | |
| KR101280873B1 (en) | Manufacturing method of jujube soybean paste | |
| KR20090038595A (en) | Healthy filling composite for korea tradition sausage and korea tradition sausage process using the same | |
| KR101048519B1 (en) | Manufacturing method of abalone Honggyetang | |
| KR100503208B1 (en) | Diet-food composition | |
| CN104799370B (en) | A kind of health drink and preparation method thereof | |
| KR100761910B1 (en) | Health food boiled chicken and Method for cooking thereof | |
| KR20060111422A (en) | Drink contain ingrediet of sea weed fusiforme | |
| KR101365911B1 (en) | Processing methods for ham hocks ham hocks | |
| CN105995702A (en) | Healthcare flavoring osmunda | |
| KR100614919B1 (en) | The fabrication method of korean medical soup with trionyx sinensis and Ogol chicken | |
| KR20180085624A (en) | Health supplement foods using crucian carp | |
| KR20100035961A (en) | Composition of gongjindan comprising nono powder of jinseung | |
| KR20090029470A (en) | Sweety flavour opuntia madical tea beverage | |
| KR20170114509A (en) | The manufacturing method of extract using the Functional chicken feet | |
| CN105166196A (en) | Coix seed-purple sweet potato health-care eye nourishing tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E90F | Notification of reason for final refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |